CRISPR Gene-Editing Technique Revolutionizes Cancer Mutation Research at MIT

MIT researchers have developed a new method to engineer specific cancer-related mutations into mouse models using CRISPR genome-editing technology, which could significantly advance drug development and understanding of tumor development. The technique bypasses the laborious traditional approach that took months or years to produce and analyze mice with a single cancer-linked mutation. The researchers hope the technique could be applied to any cancer mutation, providing potential for identifying and testing new drugs that target these mutations and understanding their distinct effects on tumor development.